the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome
Evaluation of the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome
1 other identifier
observational
80
0 countries
N/A
Brief Summary
Evaluating any possible relationship between irritable bowel syndrome occurrence and Helicobacter pylori infection
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2021
CompletedFirst Posted
Study publicly available on registry
April 19, 2021
CompletedStudy Start
First participant enrolled
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedApril 19, 2021
April 1, 2021
5 months
April 12, 2021
April 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of irritable bowel syndrome patients who had H.pylori infection
H.pylori stool antigen kits
through study completion, an average of 1 year
Study Arms (2)
Group 1
patients with Irritable Bowel Syndrome
Group 2
normal
Interventions
Eligibility Criteria
outpatient clinic patients
You may qualify if:
- All patients will be selected according to Rome IV criteria for the diagnosis of IBS, which include:
- Recurrent abdominal pain at least 1 day/week in the last 3 months, with two or more of the following criteria:
- Related to defecation
- Associated with a change in frequency of stool
- Associated with a change in form of stool. Criteria achieved for the last 3 months with symptom onset at least 6 months before diagnosis
You may not qualify if:
- Rectal bleeding
- Anemia
- Weight loss
- Onset after 50 years of age
- Recent antibiotic use
- Abnormal abdominal examination (organomegaly, lump)
- Family history of colorectal cancer.
- Family history of inflammatory bowel disease, or celiac disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
April 12, 2021
First Posted
April 19, 2021
Study Start
May 25, 2021
Primary Completion
November 1, 2021
Study Completion
January 1, 2022
Last Updated
April 19, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share